ECOR vs. CVRX, LNSR, AVR, PDEX, RCEL, INFU, LUCD, LAKE, PTHL, and OBIO
Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include CVRx (CVRX), LENSAR (LNSR), Anteris Technologies Global (AVR), Pro-Dex (PDEX), Avita Medical (RCEL), InfuSystem (INFU), Lucid Diagnostics (LUCD), Lakeland Industries (LAKE), Pheton (PTHL), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.
electroCore vs. Its Competitors
electroCore (NASDAQ:ECOR) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.
electroCore has a net margin of -46.24% compared to CVRx's net margin of -97.49%. CVRx's return on equity of -79.04% beat electroCore's return on equity.
electroCore has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, CVRx has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.
electroCore currently has a consensus price target of $25.50, suggesting a potential upside of 259.15%. CVRx has a consensus price target of $14.50, suggesting a potential upside of 114.81%. Given electroCore's stronger consensus rating and higher possible upside, equities research analysts clearly believe electroCore is more favorable than CVRx.
electroCore has higher earnings, but lower revenue than CVRx. electroCore is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.
In the previous week, CVRx had 1 more articles in the media than electroCore. MarketBeat recorded 1 mentions for CVRx and 0 mentions for electroCore. CVRx's average media sentiment score of 0.26 beat electroCore's score of 0.00 indicating that CVRx is being referred to more favorably in the news media.
26.7% of electroCore shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 19.7% of electroCore shares are owned by insiders. Comparatively, 18.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
CVRx beats electroCore on 10 of the 16 factors compared between the two stocks.
Get electroCore News Delivered to You Automatically
Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
electroCore Competitors List
Related Companies and Tools
This page (NASDAQ:ECOR) was last updated on 7/8/2025 by MarketBeat.com Staff
